Table 1

Frequency of ZnT8A positivity in T1DGC subjects recruited within 3 years of clinical diagnosis

GroupCharacteristicsDiabetes duration
nPrevalence MaleFemaleP*0–1 year 1–2 years 2–3 years P
Total1,50457.3157.3657.261.00064.52 (0.23)57.38 (0.145)51.02 (0.09)0.0002
0.0001
NHW99159.7459.7859.691.00067.16 (0.275)59.85 (0.14)53.42 (0.09)0.003
Hispanic16760.4857.6962.920.52868.52 (0.25)58.57 (0.18)53.49 (0.17)0.281
NHB24057.9257.2658.540.89662.16 (0.14)56.47 (0.12)55.56 (0.09)0.666
Asian10026.0032.6918.750.17027.27 (0.035)31.58 (0.05)20.00 (0.095)0.515
Other666.6750.001000.467100 nd50 nd50 ndnd
  • Data are n, %, or % (median ZnT8A+ index). nd, not determined.

  • *, sex association;

  • †, association with disease duration;

  • ‡, P = 7.47 × 10−9 relative to other racial/ethnic subgroups.